Skip to main content
Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze IQV IQVIA Holdings Inc.: https://finlab.finance/en/setup?stock=IQV”

IQV

IQVIA Holdings Inc. Healthcare As of 2026-06-18
Quality Above avg
Valuation Expensive
Risk Moderate
167.77 Close (USD)
+1.01% 60-day
  • Quality is above average. Operating margin sits near the 64th percentile. TTM ROE is about 22.3%.
  • Valuation is expensive. TTM P/E is in the 74th percentile, above most peers.
  • Recent volatility is moderate. 60-day annualized volatility is near the 61th percentile. Average 20-day dollar volume is about $301.1M.

Factor profile

Factor radar Neutral Valuation
42
ValuationQualityGrowthMomentumRisk / liquidity

Valuation

Indicators in this group are ranked by market percentile; lower valuation and volatility are better.

42 Neutral
TTM P/E 20.79
Pricey
Price / book 4.54
Expensive
Free-cash-flow yield (%) 9.46
Top

Historical evidence

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 You are here484-2.1% +0.8% 50.8% -18%
20-40 529-5.3% -6.7% 30.4% -13.7%
40-60 58+14.4% -11.4% 27.6% +4.1%
60-80 94+41.8% +32.6% 100% +16.1%
80-100 193+49.8% +52.5% 100% +20.9%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 20.79, placing it in the 10.0 own-history percentile, inside the 0-20 bucket.

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
Now
-5.5%
Win rate 25.7% Excess -10.3%
521d
+6.2%
Win rate 69% Excess -2.5%
116d
+24.9%
Win rate 96% Excess +10.7%
224d
60-day momentum down
+1.5%
Win rate 46.1% Excess -4.1%
551d
Insufficient data
(26d)
+26.3%
Win rate 100% Excess +5.7%
40d

Currently in “Cheap (own-history bottom third) × 60-day momentum up”: across 521 historical days, 120-day forward avg declined 5.5%, win rate 25.7%, lagged the market by 10.3%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 94,737 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.40%, a 58.3% positive-return rate, and +3.10 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

28 times historically; 60-day forward avg +1.28%, win rate 60.7%, beating the market by -0.11 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

12 times historically; 60-day forward avg -3.84%, win rate 25%, beating the market by -4.75 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze IQV IQVIA Holdings Inc.: https://finlab.finance/en/setup?stock=IQV”

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.